Who invested in Applied Molecular Evolution?
One investor is on record as having backed Applied Molecular Evolution — Developed monoclonal antibodies for cancer and autoimmune disease, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
Applied Molecular Evolution investors
No round dates are on record for Applied Molecular Evolution. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Applied Molecular Evolution are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.